Developer docs
API playgroundTry for free, no card

Search company profiles

CSO Pharma Consulting GmbH

Full company profile

uuid002hkod

Namestring
CSO Pharma Consulting GmbH
Legal namestring
CSO Pharma Consulting GmbH
Websiteurl
cso-pharma.eu
Company typeenum
Private
Founded yearint
2010
Descriptiontext

CSO Pharma Consulting GmbH is a privately held German professional consulting firm headquartered in Munich, founded in 2010 by Dr. Silke Ostermann MBA. The company delivers specialized regulatory and compliance services to pharmaceutical companies, biotech firms, wholesale distributors, and healthcare organizations across the DACH region and internationally. Its service portfolio is organized around three pillars: Compliance, Safety, and Organisation Development, encompassing pharmacovigilance (ICSR processing, PSMF preparation, QPPV and Stufenplanbeauftragter outsourcing, signal detection, PSUR/PBRER/DSUR preparation, risk management plans, PV audits, inspection readiness), medical affairs (24/7 medical hotline, medical information management, labeling and HWG compliance, xEVMPD/ISO-IDMP data entry, socialvigilance, accessible patient leaflets), quality management and GxP consulting (SOP development, audit support, serialization), GDP and wholesale license support (Großhandelserlaubnis acquisition and responsible person outsourcing), regulatory compliance, and public/private training programs delivered through partners including Forum Institut, LS Academy, and TÜV SÜD/BioM.

The underlying technology stack is minimal: CSO Pharma operates as a human-expert-delivered consulting business with no proprietary AI/ML platform or algorithm disclosed. The principal technical artifact is a password-protected ICSR-Online Portal providing document-level access control, audit trail, version control, and automated reminder functions for case safety report management. Services are delivered by a multicultural team of scientists, pharmacists, physicians, and economists qualified to assume legally mandated responsible-person roles under EU and German pharmaceutical law.

The business model is fee-for-service professional consulting on a project or retainer basis, with quote-based engagement pricing that is not publicly disclosed. Revenue is generated across operative outsourced functions (QPPV, GPO, Responsible Person for Wholesale), strategic advisory, process implementation, training delivery, and ongoing service contracts. Go-to-market relies on direct B2B outreach to regulatory, pharmacovigilance, quality, and medical affairs decision-makers, complemented by industry working group participation (MEGRA, ECA Foundation GDP-Group, Munich PV Working Group), public training programs, and inclusion in the athagoras group of healthcare service providers. The company maintains a 1-10 employee footprint with no disclosed external funding, operating as a founder-led boutique practice.

Short descriptiontext

CSO Pharma Consulting GmbH is a Munich-based pharma consulting firm founded in 2010, delivering pharmacovigilance, medical affairs, quality management, GDP, and regulatory compliance services to pharmaceutical companies, biotech firms, and wholesale distributors across Germany and internationally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMünchen, Germany
HQ citystring
München
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacovigilance consulting, medical affairs services, pharmaceutical quality management, GDP wholesale licensing, regulatory compliance consulting
Industry1 code
PRIMARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code2 codes
  • Other Management Consulting Services541618
  • Management Consulting Services54161
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Misc Health & Allied Services, Nec8090
Product category
Pharmaceutical Regulatory & Pharmacovigilance Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Professional Consulting Services
TypeProfessional Services
Description

CSO Pharma generates revenue through fee-for-service consulting engagements across pharmacovigilance, medical affairs, quality management, GDP, and regulatory compliance. Services are tailored to client needs and delivered as project-based or retainer engagements. Revenue is derived from operative support, strategic consulting, process implementation, training delivery, and outsourced functional responsibilities (e.g., acting as QPPV, GPO, or Responsible Person for Wholesale).

cso-pharma.eu
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

CSO Pharma Consulting GmbH provides fee-based professional consulting and outsourced operational services to pharmaceutical, biotech, and healthcare organizations in three core areas: Compliance (pharmacovigilance, medical affairs, quality management, GDP / wholesale licensing, regulatory compliance) and Organisation Development (process design and implementation support). Services span ICSR processing, PSMF implementation, QPPV and Stufenplanbeauftragter outsourcing, 24/7 medical enquiry hotlines, SOP development, audit support, serialization, training, and acting as Responsible Person for Wholesale. Engagements are delivered as project-based or retainer outsourced mandates rather than as discrete software products.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

CSO Pharma Consulting GmbH is a German consulting and service company founded by Dr. Silke Ostermann MBA in 2010, offering a comprehensive portfolio of professional services for pharmaceutical companies and healthcare organizations. The company operates as a single unified service offering organized around three core pillars: Compliance, Safety, and Organisation Development. The core services include Pharmakovigilance (PV) Services covering the complete portfolio from ICSR processing to full PV system implementation and QPPV responsibilities; Medical Affairs Services providing medical hotline, product information management, labeling compliance, and information officer functions; Quality Management/GxP Services for system development, SOP creation, and audit support; Regulatory Compliance for life cycle management and variation submissions; GDP/Wholesale License Support for distribution practice compliance; and Training Services for pharmacovigilance, quality management, and process implementation. The company also provides specialized sub-services including PV audits, socialvigilance, serialization support, contract services, and an ICSR-Online portal. CSO Pharma serves pharmaceutical products, medical devices, and supplements, and operates as part of the athagoras group of leading service providers.

Product and service9 records
1Pharmakovigilance Services
CategoryPharmacovigilance / Drug Safety
Description

Complete portfolio of pharmacovigilance services including ICSR processing, PV system implementation, PSMF preparation, signal detection, literature screening, PSUR/PBRER/DSUR reports, risk management plans, QPPV services, and regulatory inspection readiness support for pharmaceutical companies and marketing authorization holders.

2Medical Affairs Services
CategoryMedical Affairs
Description

Medical information and hotline services including 24/7 enquiry handling, medical writing, product information management, labeling compliance, advertising law (HWG) compliance assessment, and information officer responsibilities for pharmaceutical companies.

3Quality Management (QM) / GxP Services
CategoryQuality Management / GxP Consulting
Description

Quality management system development, SOP creation, audit support, self-inspection services, process optimization, and integration with GxP standards (GDP, GMP, GVP, GCP, GLP, ISO) for pharmaceutical and healthcare organizations.

4Regulatory Compliance / Regulatory Affairs
CategoryRegulatory Affairs
Description

Life cycle management including classification and submission of variations, WHO certificates, CoPPs, PSUR submissions, risk management plan updates, deficiency letter responses, and product information text reviews for pharmaceutical companies.

5GDP / Wholesale License Support
CategoryGDP / Wholesale Licensing
Description

Good Distribution Practice implementation, wholesale license (Großhandelserlaubnis) obtainment support, GDP responsible person services, supplier and customer qualification, and GDP audit support for pharmaceutical wholesale distributors.

6Training Services
CategoryProfessional Training
Description

Hands-on training programs covering pharmacovigilance, quality management, GxP standards, process development, and change management with practice-oriented workshops and interactive sessions for pharmaceutical industry professionals.

7Organisation Development
CategoryOrganisation Development Consulting
Description

Strategic organisational consulting to help pharmaceutical companies establish compliant and efficient processes, including process analysis, implementation support, and continuous improvement.

8Audit and Inspection Readiness Services
CategoryAudit and Compliance Support
Description

Pharmacovigilance audit services, shared audits, internal self-inspection support, regulatory inspection readiness preparation, documentation preparation, mock audits, and corrective action implementation for pharmaceutical companies.

9ICSR-Online Portal Service
CategoryPharmacovigilance Operations Platform
Description

Password-protected 24/7 online portal for individual case safety report management with document-level access control, audit trail, version control, and automated reminder functions, delivered as part of CSO Pharma's pharmacovigilance service.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CSO Pharma is part of the athagoras group, a group of leading service providers united in supporting pharma, biotech, and healthcare companies to achieve fast and efficient market access for their products. The group addresses challenges including increasing competition, pricing pressure, volatile supply chains, and regulatory pressure. CSO Pharma contributes its expertise in compliance, safety, and organization development within the group structure, enabling the group to offer a broader suite of integrated healthcare services.

Strategic tierCoreTypeOthers
Description

MEGRA is the Middle European Association for Regulatory Affairs. CSO Pharma is a member and participates in MEGRA Training Committee activities. MEGRA organizes regular training events on current topics such as pharmacovigilance audits and quality defects, providing CSO Pharma with access to industry knowledge, networking, and thought leadership opportunities.

Strategic tierModerateTypeOthers
Description

The GDP-Group is an interest group of the ECA Foundation focused on Good Distribution Practice. Membership enables CSO Pharma to stay current with GDP regulatory developments, participate in GDP audits guidance initiatives, and network with other GDP professionals.

4Pharmakovigilanz Arbeitskreis München
Strategic tierModerateTypeOthers
Description

The Munich Pharmacovigilance Working Group is a professional network for PV practitioners in the Munich region. Membership supports knowledge exchange and professional development in pharmacovigilance.

cso-pharma.eu
5PV Audit Group (LinkedIn)
Strategic tierMinorTypeOthers
Description

A LinkedIn-based professional network for pharmacovigilance audit practitioners. CSO Pharma participates to exchange audit practices, regulatory developments, and benchmarking information with peers.

cso-pharma.eu
Strategic tierMinorTypeOthers
Description

A XING-based professional network focused on Good Distribution Practice. CSO Pharma participates in this group for GDP knowledge exchange and professional networking within the German-speaking pharmaceutical distribution community.

Strategic tierModerateTypeGTM or Marketing Partner
Description

CSO Pharma partners with Forum Institut to deliver GVP-Auditor training courses and Pharmakovigilanz Compliance seminars. CSO Pharma personnel serve as instructors for these public training programs, generating leads while building thought leadership in the pharmacovigilance auditing space.

Strategic tierMinorTypeGTM or Marketing Partner
Description

CSO Pharma collaborates with LS Academy to deliver training programs on Risk Management Plans and PSMF (Pharmacovigilance System Master File) creation and implementation. The partnership extends CSO Pharma's reach in the training market.

9TÜV SÜD Akademie / BioM
Strategic tierMinorTypeGTM or Marketing Partner
Description

CSO Pharma participates in the TÜV SÜD (in collaboration with BioM) modular training program 'Manager Klinische Entwicklung Pharma & Biotechnologie' held annually in Munich and Frankfurt. This engagement positions CSO Pharma within the biotech education ecosystem.

cso-pharma.eu
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global CRO and life sciences services giant offering pharmacovigilance, regulatory, quality, and consulting across the full pharma value chain. Serves as a broader incumbent against which CSO Pharma competes on specialized EU/German compliance depth.

TypeDirect peer
Description

Life sciences regulatory and pharmacovigilance consultancy with deep EU expertise, serving pharma and biotech across regulatory strategy, clinical, and post-marketing safety — directly overlaps CSO Pharma's core PV and regulatory services.

TypeDirect peer
Description

Pharmaceutical regulatory affairs and development consultancy providing EU regulatory strategy, submissions, and lifecycle support — comparable to CSO Pharma's regulatory affairs service line.

TypeDirect peer
Description

Pharma and biotech quality and compliance consultancy specializing in GMP, validation, and regulatory support. Comparable boutique-mid consulting model focused on GxP services to life sciences clients.

TypeDirect peer
Description

Regulatory affairs, pharmacovigilance, and compliance consulting firm for pharma and biotech, with a focus on EU frameworks. Similar boutique-mid profile with overlapping PV, regulatory, and quality service lines.

6Maetrics
TypeDirect peer
Description

Life sciences quality, compliance, and regulatory consulting firm offering GxP, validation, and quality management services to pharma and medical device manufacturers — directly comparable in QM/GxP scope.

7Diamond Pharma Services
TypeDirect peer
Description

UK-based pharma regulatory affairs, pharmacovigilance, and quality consultancy supporting MAHs and biotech — overlaps CSO Pharma's PV and regulatory lifecycle services, though with a UK rather than German base.

8NNIT Life Sciences
TypeEmerging player
Description

IT and consulting services provider to life sciences, with GxP, regulatory, and digital compliance offerings. Adjacent but growing overlap with CSO Pharma's regulatory and quality management consulting.

TypeDirect peer
Description

Directly comparable pharma regulatory affairs, pharmacovigilance, and quality management consulting firm serving MAHs and biotech. Operates with a similar service portfolio (PV, QPPV, regulatory, QM) across multiple geographies, but at significantly greater scale.

TypeDirect peer
Description

Specialist GxP compliance, pharmacovigilance, and regulatory consulting firm serving pharma, biotech, and medical device companies. Closely comparable service offering including PV, quality, and regulatory affairs consulting.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CSO Pharma Consulting GmbH

Pharmaceutical Regulatory & Pharmacovigilance Consultingcso-pharma.eu

CSO Pharma Consulting GmbH is a Munich-based pharma consulting firm founded in 2010, delivering pharmacovigilance, medical affairs, quality management, GDP, and regulatory compliance services to pharmaceutical companies, biotech firms, and wholesale distributors across Germany and internationally.

What CSO Pharma Consulting GmbH does

CSO Pharma Consulting GmbH is a privately held German professional consulting firm headquartered in Munich, founded in 2010 by Dr. Silke Ostermann MBA. The company delivers specialized regulatory and compliance services to pharmaceutical companies, biotech firms, wholesale distributors, and healthcare organizations across the DACH region and internationally. Its service portfolio is organized around three pillars: Compliance, Safety, and Organisation Development, encompassing pharmacovigilance (ICSR processing, PSMF preparation, QPPV and Stufenplanbeauftragter outsourcing, signal detection, PSUR/PBRER/DSUR preparation, risk management plans, PV audits, inspection readiness), medical affairs (24/7 medical hotline, medical information management, labeling and HWG compliance, xEVMPD/ISO-IDMP data entry, socialvigilance, accessible patient leaflets), quality management and GxP consulting (SOP development, audit support, serialization), GDP and wholesale license support (Großhandelserlaubnis acquisition and responsible person outsourcing), regulatory compliance, and public/private training programs delivered through partners including Forum Institut, LS Academy, and TÜV SÜD/BioM.

The underlying technology stack is minimal: CSO Pharma operates as a human-expert-delivered consulting business with no proprietary AI/ML platform or algorithm disclosed. The principal technical artifact is a password-protected ICSR-Online Portal providing document-level access control, audit trail, version control, and automated reminder functions for case safety report management. Services are delivered by a multicultural team of scientists, pharmacists, physicians, and economists qualified to assume legally mandated responsible-person roles under EU and German pharmaceutical law.

The business model is fee-for-service professional consulting on a project or retainer basis, with quote-based engagement pricing that is not publicly disclosed. Revenue is generated across operative outsourced functions (QPPV, GPO, Responsible Person for Wholesale), strategic advisory, process implementation, training delivery, and ongoing service contracts. Go-to-market relies on direct B2B outreach to regulatory, pharmacovigilance, quality, and medical affairs decision-makers, complemented by industry working group participation (MEGRA, ECA Foundation GDP-Group, Munich PV Working Group), public training programs, and inclusion in the athagoras group of healthcare service providers. The company maintains a 1-10 employee footprint with no disclosed external funding, operating as a founder-led boutique practice.

CSO Pharma Consulting GmbH firmographics

Firmographics
Name
CSO Pharma Consulting GmbH
Legal name
CSO Pharma Consulting GmbH
Website
https://cso-pharma.eu
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
1–10 employees
Short description
CSO Pharma Consulting GmbH is a Munich-based pharma consulting firm founded in 2010, delivering pharmacovigilance, medical affairs, quality management, GDP, and regulatory compliance services to pharmaceutical companies, biotech firms, and wholesale distributors across Germany and internationally.
Ownership category
akta.pro rank

CSO Pharma Consulting GmbH industry classification

Industry
Product category
Pharmaceutical Regulatory & Pharmacovigilance Consulting
NAICS
Other Management Consulting Services (541618), Management Consulting Services (54161)
SIC
Services-Management Consulting Services (8742), Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Pharmacovigilance consulting
  • Medical affairs services
  • Pharmaceutical quality management
  • GDP wholesale licensing
  • Regulatory compliance consulting

Where CSO Pharma Consulting GmbH is headquartered

Location

Headquarters

HQ city
München
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

CSO Pharma Consulting GmbH business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Professional Consulting Services: CSO Pharma generates revenue through fee-for-service consulting engagements across pharmacovigilance, medical affairs, quality management, GDP, and regulatory compliance. Services are tailored to client needs and delivered as project-based or retainer engagements. Revenue is derived from operative support, strategic consulting, process implementation, training delivery, and outsourced functional responsibilities (e.g., acting as QPPV, GPO, or Responsible Person for Wholesale).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

CSO Pharma Consulting GmbH product offering

Product offering

Core offering

CSO Pharma Consulting GmbH provides fee-based professional consulting and outsourced operational services to pharmaceutical, biotech, and healthcare organizations in three core areas: Compliance (pharmacovigilance, medical affairs, quality management, GDP / wholesale licensing, regulatory compliance) and Organisation Development (process design and implementation support). Services span ICSR processing, PSMF implementation, QPPV and Stufenplanbeauftragter outsourcing, 24/7 medical enquiry hotlines, SOP development, audit support, serialization, training, and acting as Responsible Person for Wholesale. Engagements are delivered as project-based or retainer outsourced mandates rather than as discrete software products.

Product overview

CSO Pharma Consulting GmbH is a German consulting and service company founded by Dr. Silke Ostermann MBA in 2010, offering a comprehensive portfolio of professional services for pharmaceutical companies and healthcare organizations. The company operates as a single unified service offering organized around three core pillars: Compliance, Safety, and Organisation Development. The core services include Pharmakovigilance (PV) Services covering the complete portfolio from ICSR processing to full PV system implementation and QPPV responsibilities; Medical Affairs Services providing medical hotline, product information management, labeling compliance, and information officer functions; Quality Management/GxP Services for system development, SOP creation, and audit support; Regulatory Compliance for life cycle management and variation submissions; GDP/Wholesale License Support for distribution practice compliance; and Training Services for pharmacovigilance, quality management, and process implementation. The company also provides specialized sub-services including PV audits, socialvigilance, serialization support, contract services, and an ICSR-Online portal. CSO Pharma serves pharmaceutical products, medical devices, and supplements, and operates as part of the athagoras group of leading service providers.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmakovigilance Services Complete portfolio of pharmacovigilance services including ICSR processing, PV system implementation, PSMF preparation, signal detection, literature screening, PSUR/PBRER/DSUR reports, risk management plans, QPPV services, and regulatory inspection readiness support for pharmaceutical companies and marketing authorization holders.
  • Medical Affairs Services Medical information and hotline services including 24/7 enquiry handling, medical writing, product information management, labeling compliance, advertising law (HWG) compliance assessment, and information officer responsibilities for pharmaceutical companies.
  • Quality Management (QM) / GxP Services Quality management system development, SOP creation, audit support, self-inspection services, process optimization, and integration with GxP standards (GDP, GMP, GVP, GCP, GLP, ISO) for pharmaceutical and healthcare organizations.
  • Regulatory Compliance / Regulatory Affairs Life cycle management including classification and submission of variations, WHO certificates, CoPPs, PSUR submissions, risk management plan updates, deficiency letter responses, and product information text reviews for pharmaceutical companies.
  • GDP / Wholesale License Support Good Distribution Practice implementation, wholesale license (Großhandelserlaubnis) obtainment support, GDP responsible person services, supplier and customer qualification, and GDP audit support for pharmaceutical wholesale distributors.
  • Training Services Hands-on training programs covering pharmacovigilance, quality management, GxP standards, process development, and change management with practice-oriented workshops and interactive sessions for pharmaceutical industry professionals.
  • Organisation Development Strategic organisational consulting to help pharmaceutical companies establish compliant and efficient processes, including process analysis, implementation support, and continuous improvement.
  • Audit and Inspection Readiness Services Pharmacovigilance audit services, shared audits, internal self-inspection support, regulatory inspection readiness preparation, documentation preparation, mock audits, and corrective action implementation for pharmaceutical companies.
  • ICSR-Online Portal Service Password-protected 24/7 online portal for individual case safety report management with document-level access control, audit trail, version control, and automated reminder functions, delivered as part of CSO Pharma's pharmacovigilance service.

Companies that use CSO Pharma Consulting GmbH

Customer profile

Segments4 records

Ideal customer profiles4 records

CSO Pharma Consulting GmbH technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

CSO Pharma Consulting GmbH partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core, moderate and minor.

  • athagoras groupcoreStrategic or Co-development PartnerCSO Pharma is part of the athagoras group, a group of leading service providers united in supporting pharma, biotech, and healthcare companies to achieve fast and efficient market access for their products. The group addresses challenges including increasing competition, pricing pressure, volatile supply chains, and regulatory pressure. CSO Pharma contributes its expertise in compliance, safety, and organization development within the group structure, enabling the group to offer a broader suite of integrated healthcare services.
  • MEGRA (Mitteleuropäische Gesellschaft für Regulatory Affairs)coreOthersMEGRA is the Middle European Association for Regulatory Affairs. CSO Pharma is a member and participates in MEGRA Training Committee activities. MEGRA organizes regular training events on current topics such as pharmacovigilance audits and quality defects, providing CSO Pharma with access to industry knowledge, networking, and thought leadership opportunities.
  • GDP-Group (Interest Group of the ECA Foundation)moderateOthersThe GDP-Group is an interest group of the ECA Foundation focused on Good Distribution Practice. Membership enables CSO Pharma to stay current with GDP regulatory developments, participate in GDP audits guidance initiatives, and network with other GDP professionals.
  • Pharmakovigilanz Arbeitskreis MünchenmoderateOthersThe Munich Pharmacovigilance Working Group is a professional network for PV practitioners in the Munich region. Membership supports knowledge exchange and professional development in pharmacovigilance.
  • PV Audit Group (LinkedIn)minorOthersA LinkedIn-based professional network for pharmacovigilance audit practitioners. CSO Pharma participates to exchange audit practices, regulatory developments, and benchmarking information with peers.
  • GDP Gruppe (XING)minorOthersA XING-based professional network focused on Good Distribution Practice. CSO Pharma participates in this group for GDP knowledge exchange and professional networking within the German-speaking pharmaceutical distribution community.
  • Forum - Institut für Management GmbHmoderateGTM or Marketing PartnerCSO Pharma partners with Forum Institut to deliver GVP-Auditor training courses and Pharmakovigilanz Compliance seminars. CSO Pharma personnel serve as instructors for these public training programs, generating leads while building thought leadership in the pharmacovigilance auditing space.
  • LS AcademyminorGTM or Marketing PartnerCSO Pharma collaborates with LS Academy to deliver training programs on Risk Management Plans and PSMF (Pharmacovigilance System Master File) creation and implementation. The partnership extends CSO Pharma's reach in the training market.
  • TÜV SÜD Akademie / BioMminorGTM or Marketing PartnerCSO Pharma participates in the TÜV SÜD (in collaboration with BioM) modular training program 'Manager Klinische Entwicklung Pharma & Biotechnologie' held annually in Munich and Frankfurt. This engagement positions CSO Pharma within the biotech education ecosystem.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

CSO Pharma Consulting GmbH competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: Global CRO and life sciences services giant offering pharmacovigilance, regulatory, quality, and consulting across the full pharma value chain. Serves as a broader incumbent against which CSO Pharma competes on specialized EU/German compliance depth.

Direct peers

  • Voisin Consulting Life Sciences (VCLS): Life sciences regulatory and pharmacovigilance consultancy with deep EU expertise, serving pharma and biotech across regulatory strategy, clinical, and post-marketing safety — directly overlaps CSO Pharma's core PV and regulatory services.
  • Remap Consulting: Pharmaceutical regulatory affairs and development consultancy providing EU regulatory strategy, submissions, and lifecycle support — comparable to CSO Pharma's regulatory affairs service line.
  • QbD Group: Pharma and biotech quality and compliance consultancy specializing in GMP, validation, and regulatory support. Comparable boutique-mid consulting model focused on GxP services to life sciences clients.
  • Arriello: Regulatory affairs, pharmacovigilance, and compliance consulting firm for pharma and biotech, with a focus on EU frameworks. Similar boutique-mid profile with overlapping PV, regulatory, and quality service lines.
  • Maetrics: Life sciences quality, compliance, and regulatory consulting firm offering GxP, validation, and quality management services to pharma and medical device manufacturers — directly comparable in QM/GxP scope.
  • Diamond Pharma Services: UK-based pharma regulatory affairs, pharmacovigilance, and quality consultancy supporting MAHs and biotech — overlaps CSO Pharma's PV and regulatory lifecycle services, though with a UK rather than German base.
  • PharmaLex (now part of GBA Group): Directly comparable pharma regulatory affairs, pharmacovigilance, and quality management consulting firm serving MAHs and biotech. Operates with a similar service portfolio (PV, QPPV, regulatory, QM) across multiple geographies, but at significantly greater scale.
  • ProPharma Group: Specialist GxP compliance, pharmacovigilance, and regulatory consulting firm serving pharma, biotech, and medical device companies. Closely comparable service offering including PV, quality, and regulatory affairs consulting.

Emerging players

  • NNIT Life Sciences: IT and consulting services provider to life sciences, with GxP, regulatory, and digital compliance offerings. Adjacent but growing overlap with CSO Pharma's regulatory and quality management consulting.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

CSO Pharma Consulting GmbH social profiles

Digital presence

CSO Pharma Consulting GmbH financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CSO Pharma Consulting GmbH leadership team

Management profile

Number of profiles

Profiles1 record

CSO Pharma Consulting GmbH funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CSO Pharma Consulting GmbH M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CSO Pharma Consulting GmbH

What does CSO Pharma Consulting GmbH do?

CSO Pharma Consulting GmbH provides fee-based professional consulting and outsourced operational services to pharmaceutical, biotech, and healthcare organizations in three core areas: Compliance (pharmacovigilance, medical affairs, quality management, GDP / wholesale licensing, regulatory compliance) and Organisation Development (process design and implementation support). Services span ICSR processing, PSMF implementation, QPPV and Stufenplanbeauftragter outsourcing, 24/7 medical enquiry hotlines, SOP development, audit support, serialization, training, and acting as Responsible Person for Wholesale. Engagements are delivered as project-based or retainer outsourced mandates rather than as discrete software products.

Is CSO Pharma Consulting GmbH a public or private company?

CSO Pharma Consulting GmbH is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was CSO Pharma Consulting GmbH founded?

CSO Pharma Consulting GmbH was founded in 2010. It employs 1 to 10 people.

Where is CSO Pharma Consulting GmbH based?

CSO Pharma Consulting GmbH is headquartered in München, Germany, in the Europe region.

How does CSO Pharma Consulting GmbH make money?

One revenue line is on record: professional Consulting Services.

Who are CSO Pharma Consulting GmbH's main competitors?

IQVIA is listed as a broad incumbent. Direct peers are Voisin Consulting Life Sciences (VCLS), Remap Consulting, QbD Group, Arriello, Maetrics, Diamond Pharma Services, PharmaLex (now part of GBA Group) and ProPharma Group. NNIT Life Sciences is listed as an emerging player.

Does CSO Pharma Consulting GmbH have an API?

No public API is recorded for CSO Pharma Consulting GmbH.

What industry is CSO Pharma Consulting GmbH in?

CSO Pharma Consulting GmbH's product category is Pharmaceutical Regulatory & Pharmacovigilance Consulting. Its primary akta.pro industry code is HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight). Its NAICS code is 541618 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales